This is a firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Pro-Change Behavior Systems, Inc., a woman-owned small business. The contract, valued at $905,897.09, is for clinical management services related to addressing pressing public health concerns. The contract is not set aside. Pro-Change Behavior Systems, Inc., doing business as Prochange Behavior Solutions, specializes in developing innovative behavior change programs and interventions...
The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $525,235.25 definitive contract to Geisinger Clinic, doing business as Geisinger Health Group, for a demonstration project titled "Combining Trust, Technology & Theory in the Community to Prevent Diabetes: A Demonstration Project with Black Barbers & Stylists". The contract, which is not set aside, has a completion date of September 28, 2024. Geisinger Clinic is a subsidiary of Geisinger Health System...
Pro-Change Behavior Systems, Inc., doing business as Prochange Behavior Solutions, has been awarded a definitive contract valued at $646,966.53 by the Centers for Disease Control and Prevention (CDC) to support Topic 2.1 of the agency's Fiscal Year 2021 Broad Agency Announcement. Under this contract, Prochange will leverage technology and behavioral theory to increase readiness for and enrollment in the Diabetes Prevention Program. Performance will take place in Wakefield and South Kingstown,...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $4,111,165.58 firm fixed-price definitive contract to Copial Business Strategists, LLC, a minority-owned, 8(a) small disadvantaged business, for administrative services in support of the Division of Diabetes Translation. The contract was awarded on January 1, 2018 and has a completion date of May 31, 2021. Copial Business Strategists specializes in business consulting services and has been...
The Centers for Disease Control and Prevention (CDC) awarded a $78,743 firm fixed price purchase order to Biocentric, Inc. to deliver a serious health game supporting a lifestyle change program for diabetes prevention. As the final report under the contract, Biocentric will report on outcomes of developing and deploying a digital game to educate at-risk individuals on diabetes prevention best practices. No subcontractors or set aside designations were specified. The CDC works extensively with...
This is a $295,806.65 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Kamin Consulting Inc., doing business as Yumlish. Yumlish is a minority-owned, woman-owned small business that specializes in developing technology-enabled solutions for chronic disease management and prevention, with a focus on underserved populations. The contract, which does not have a set-aside designation, is for the purpose of "Leveraging Technology and Systems...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a definitive contract valued at approximately $750,000 to the Association of State and Territorial Chronic Disease Program Directors, Inc. doing business as the Association of State & Territorial Chronic Disease Program Directors. The contract is being awarded under Fiscal Year 2021 Broad Agency Announcement Topic 2 to develop text to prevent diabetes. Performance will take place in Decatur,...
This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Peraton Inc., a leading provider of national security solutions and technologies to the U.S. federal government. The contract, valued at $4,113,377.76, is for continuing to develop and implement the National Diabetes Prevention Program Operations Center. The contract is not set aside for any specific business type. As the prime contractor, Peraton has subcontracted a portion of the work to...
Pro-Change Behavior Systems, Inc., doing business as Prochange Behavior Solutions, has been awarded a definitive firm fixed price contract valued at one million four hundred fifty-five thousand seven hundred twenty-nine dollars and eighty-five cents ($1,455,729.85) by the Centers for Disease Control and Prevention to evaluate emerging infections during pregnancy and their prevention. As the prime contractor, Prochange will leverage its expertise in health behavior change and disease prevention...
The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $220,266.39 firm fixed price purchase order contract to Deutsche Diabetes Forschungsgesellschaft E.V, a German non-profit organization, to conduct a diabetes study within U.S. adults. The contract, which does not have a set-aside designation, funds mathematical modeling and risk score analysis to forecast diabetes prevalence and assess the impact of various risk factors, including the...